Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page
- Check5 days agoChange DetectedThe THALES trial record is now displayed, describing a completed study of ticagrelor plus aspirin for preventing stroke or death after acute ischemic stroke or transient ischemic attack. It includes participant criteria, study design and outcomes, site locations, publications, and study documents.SummaryDifference100%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 access error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with a generic error view. This indicates an access issue rather than a content update.SummaryDifference15%

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.